In such a way that the referred study showed that the expression levels of GCN5 is increased in primary human colon cancers and that GCN5 suppression, by both genetic and pharmacological approaches, inhibits human colon cancer cell proliferation (25). This evidence concerns the gene KAT2B and malignant colon neoplasm.